Financials

  • Market Capitalization 11.17 B
  • Employee 3 100
  • Founded 1976
  • CEO Charles R. Kummeth
  • Website www.bio-techne.com
  • Headquarter Minnesota, United States
  • FIGI BBG000C15114
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
111.85
Price to sales ratio
6.74
Dividends per share
0.32
Dividend yield %
0.62

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
828
AXSM
Axsome Therapeutics, Inc. - Common Stock
228.28 USD-2.36%-5.79%-9.79%+75.33%11.75 B USD
843
BMRN
BioMarin Pharmaceutical Inc. - Common Stock
59.20 USD+0.14%-0.74%+5.56%+1.02%11.44 B USD
878
KRYS
Krystal Biotech, Inc. - Common Stock
363.44 USD-0.65%-3.21%+11.44%+94.22%10.71 B USD
881
ABVX
Abivax SA - American Depositary Shares
135.98 USD-2.80%-4.58%+36.53%+1410.89%10.68 B USD

Frequently asked questions about Bio-Techne Corp - Common Stock

What is the Bio-Techne Corp - Common Stock stock price today?

The current price of Bio-Techne Corp - Common Stock (TECH) is 71.36. Over the past 24 hours, the stock has changed by +0.08%. Follow the TECH chart for real-time price dynamics.

What is the stock ticker of Bio-Techne Corp - Common Stock?

Bio-Techne Corp - Common Stock trades under the ticker TECH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Bio-Techne Corp - Common Stock stock going up?

TECH has changed by +0.62% over the last week, +32.00% over the last month, and +32.96% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Bio-Techne Corp - Common Stock release financial reports?

Yes. You can track Bio-Techne Corp - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Bio-Techne Corp - Common Stock net income for the last quarter?

Bio-Techne Corp - Common Stock reported net income of 51.05 M for the last quarter. The previous quarter showed 38.01 M, which means net income changed by +34.30%.

How many employees does Bio-Techne Corp - Common Stock have?

As of the latest available data, Bio-Techne Corp - Common Stock has 3 100 employees. Workforce size can provide additional context about the company's scale and operations.

What is Bio-Techne Corp - Common Stock EBITDA?

Bio-Techne Corp - Common Stock EBITDA is 99.66 M, and its EBITDA margin is 32%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Bio-Techne Corp - Common Stock stock?

You can buy Bio-Techne Corp - Common Stock (TECH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Bio-Techne Corp - Common Stock stock?

Investing in Bio-Techne Corp - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TECH chart and related analysis on metatrader.com as part of your research.

Bio-Techne Corp - Common Stock

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

News